Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
First procedure of its kind performed in US | FDA clears heart preservation tech | Cardiologist impaled by branch | TAVR timing
Wednesday, September 23, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

First heart procedure of its kind performed in US after careful planning

Specialists from the fields of interventional cardiology and cardiac surgery collaborated to perform what is believed to be the first completely catheter-based Fontan procedure in U.S. history. The young patient's recovery was much easier than it would have been otherwise. 

READ MORE >
The Nicklaus Children’s Hospital Heart Institute was the first to perform a completely catheter-based Fontan procedure. Rather than using open-heart surgery to complete the child’s Fontan circulation, the 2-year-old born with a double-outlet right ventricle underwent a catheter-based approach to avoid open-heart surgery.
Share on Twitter Share on Facebook Share on Linkedin

First heart procedure of its kind performed in US after careful planning

Share on Twitter Share on Facebook Share on Linkedin
The Nicklaus Children’s Hospital Heart Institute was the first to perform a completely catheter-based Fontan procedure. Rather than using open-heart surgery to complete the child’s Fontan circulation, the 2-year-old born with a double-outlet right ventricle underwent a catheter-based approach to avoid open-heart surgery.
Specialists from the fields of interventional cardiology and cardiac surgery collaborated to perform what is believed to be the first completely catheter-based Fontan procedure in U.S. history. The young patient's recovery was much easier than it would have been otherwise. 
READ MORE >

FDA clears new heart preservation system for transplants

The news comes as clinical evidence supporting heart preservation at 50 degrees F (10 degrees C) continues to grow.

READ MORE >
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Traferox Technologies' X°Port Heart Preservation System. The new device offers static 10°C (50°F) heart preservation during transport prior to transplantation, which has been shown in studies to improve outcomes.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new heart preservation system for transplants

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Traferox Technologies' X°Port Heart Preservation System. The new device offers static 10°C (50°F) heart preservation during transport prior to transplantation, which has been shown in studies to improve outcomes.
The news comes as clinical evidence supporting heart preservation at 50 degrees F (10 degrees C) continues to grow.
READ MORE >

Cardiologist impaled by tree branch makes a full recovery

The doctor, visiting Montana from Pennsylvania for a ski trip, says he did not even realize at first what had happened.

READ MORE >
Skiing
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist impaled by tree branch makes a full recovery

Share on Twitter Share on Facebook Share on Linkedin
Skiing
The doctor, visiting Montana from Pennsylvania for a ski trip, says he did not even realize at first what had happened.
READ MORE >

TAVR timing: Waiting more than 6 months may hurt survival odds

When heart patients are diagnosed with severe AS, how quickly do they need to undergo TAVR? That was the focus of a new analysis published in Open Heart.

READ MORE >
wait times waiting hour glass calendar delay
Share on Twitter Share on Facebook Share on Linkedin

TAVR timing: Waiting more than 6 months may hurt survival odds

Share on Twitter Share on Facebook Share on Linkedin
wait times waiting hour glass calendar delay
When heart patients are diagnosed with severe AS, how quickly do they need to undergo TAVR? That was the focus of a new analysis published in Open Heart.
READ MORE >

Featured Articles

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 

READ MORE >
Jennifer S. Lawton, MD
Share on Twitter Share on Facebook Share on Linkedin

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Share on Twitter Share on Facebook Share on Linkedin
Jennifer S. Lawton, MD
Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 
READ MORE >

AI gaining ground in electrophysiology, but clinicians still run the show

Even as AI is used more and more in the field, cardiologists and other clinicians are at the heart of patient care. 

READ MORE >
Sanjiv Narayan, MBChB, MD, MSc, FRCP, an American Heart Association volunteer, Director of the Electrophysiology Research and Atrial Fibrillation Program, and Co-Founder of the Stanford Arrhythmia Center, at Stanford Medicine, spoke in sessions at the European Society of Cardiology (ESC) 2026 Congress about the use of artificial intelligence in AFib care, using smarter detection to enable better outcomes.
Share on Twitter Share on Facebook Share on Linkedin

AI gaining ground in electrophysiology, but clinicians still run the show

Share on Twitter Share on Facebook Share on Linkedin
Sanjiv Narayan, MBChB, MD, MSc, FRCP, an American Heart Association volunteer, Director of the Electrophysiology Research and Atrial Fibrillation Program, and Co-Founder of the Stanford Arrhythmia Center, at Stanford Medicine, spoke in sessions at the European Society of Cardiology (ESC) 2026 Congress about the use of artificial intelligence in AFib care, using smarter detection to enable better outcomes.
Even as AI is used more and more in the field, cardiologists and other clinicians are at the heart of patient care. 
READ MORE >

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.

READ MORE >
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.
READ MORE >

Photon-counting CT accurately screens TAVR patients for signs of valve dysfunction

Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Photon-counting CT accurately screens TAVR patients for signs of valve dysfunction

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 
READ MORE >

In Case You Missed It

New ESC heart failure guidelines include major updates

The new guidelines, published in European Heart Journal and presented at ESC Congress 2026, show just how much heart failure care has evolved in recent years.

READ MORE >
The European Society of Cardiology (ESC) Congress 2023 meeting. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

New ESC heart failure guidelines include major updates

Share on Twitter Share on Facebook Share on Linkedin
The European Society of Cardiology (ESC) Congress 2023 meeting. Photo by Dave Fornell
The new guidelines, published in European Heart Journal and presented at ESC Congress 2026, show just how much heart failure care has evolved in recent years.
READ MORE >

Boston Scientific removes imaging catheters from market due to risk of injury

The issue, brought on by a manufacturing defect, has been linked to two serious injuries. The FDA shared an early alert about the situation as it continues its investigation. 

READ MORE >
The U.S. Food and Drug Administration (FDA) is warning the public about an ongoing safety issue with certain intravascular catheters manufactured by Boston Scientific. These devices are being removed from the market, and Boston Scientific has officially decided to discontinue them going forward. The devices in question are Boston Scientific’s single-use Imager II Angiographic Catheters, which interventional cardiologists, vascular surgeons and interventional radiologists.
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific removes imaging catheters from market due to risk of injury

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) is warning the public about an ongoing safety issue with certain intravascular catheters manufactured by Boston Scientific. These devices are being removed from the market, and Boston Scientific has officially decided to discontinue them going forward. The devices in question are Boston Scientific’s single-use Imager II Angiographic Catheters, which interventional cardiologists, vascular surgeons and interventional radiologists.
The issue, brought on by a manufacturing defect, has been linked to two serious injuries. The FDA shared an early alert about the situation as it continues its investigation. 
READ MORE >

TAVR and PCI: When heart patients need both, does the order matter?

Many patients who need TAVR also present with coronary artery disease. According to new data presented at ESC Congress 2026, performing TAVR first is noninferior to performing PCI first. 

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

TAVR and PCI: When heart patients need both, does the order matter?

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
Many patients who need TAVR also present with coronary artery disease. According to new data presented at ESC Congress 2026, performing TAVR first is noninferior to performing PCI first. 
READ MORE >

In Other News

Mayo Clinic, Thermo Fisher Scientific launch new AI-supported diagnostics company

The new entity, Precure, will be owned by both groups. Its work in detecting early disease for timely intervention stems from a research project launched this summer. The Mayo Clinic said Precure will make the results of that initiative actionable.

READ MORE >
Mayo Clinic was listed the No. 3 top cardiovascular hospital in the nation by U.S. News and World Report.
Share on Twitter Share on Facebook Share on Linkedin

Mayo Clinic, Thermo Fisher Scientific launch new AI-supported diagnostics company

Share on Twitter Share on Facebook Share on Linkedin
Mayo Clinic was listed the No. 3 top cardiovascular hospital in the nation by U.S. News and World Report.
The new entity, Precure, will be owned by both groups. Its work in detecting early disease for timely intervention stems from a research project launched this summer. The Mayo Clinic said Precure will make the results of that initiative actionable.
READ MORE >

Federal judge declines to intervene in Cigna’s refusal to pay $3M No Surprises Act award

The judge did not rule that Cigna was justified in refusing to pay but did agree that, under provisions of the NSA, federal courts have no right to compel payments. 

READ MORE >
Cigna, one of the nation’s largest health insurance providers, announced new priorities for its capital deployment, including steering an additional $450 million into Cigna Ventures.
Share on Twitter Share on Facebook Share on Linkedin

Federal judge declines to intervene in Cigna’s refusal to pay $3M No Surprises Act award

Share on Twitter Share on Facebook Share on Linkedin
Cigna, one of the nation’s largest health insurance providers, announced new priorities for its capital deployment, including steering an additional $450 million into Cigna Ventures.
The judge did not rule that Cigna was justified in refusing to pay but did agree that, under provisions of the NSA, federal courts have no right to compel payments. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Coverage changes for heart failure & TAVR | The push to make medical training more affordable | BP drug recalled | Stroke rehab
First procedure of its kind performed in US | FDA clears heart preservation tech | Cardiologist impaled by branch | TAVR timing
Cardiologists named to USPSTF | The top children’s heart hospitals | A decade of success | Record-breaking attendance
FDA approves new drug-eluting balloon | AI's role in EP | Screening for valve dysfunction after TAVR | AHA to honor surgeon
AEDs recalled | Soccer player sues her cardiologist | FDA approves small leadless pacemaker | J&J sells heart tech to startup
Scientific statement takes on CKD in women | The growing roles of 3D printing & VR | Chronic stress & the heart | Unlocking data
BP drug recalled | FDA approves new leadless pacemaker | Early reactions to TAVR changes | Cardiologists accused of fraud
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup